Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study of SOX vs mFOLFOX6 as Neoadjuvant Chemotherapy in Patients With Resectable Rectal Cancer (KSCC1301).

NCT02280070 is registered in ClinicalTrials.gov with Clinical Research Support Center Kyush as lead sponsor.

NCT NCT02280070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02280070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study of SOX vs mFOLFOX6 as Neoadjuvant Chemotherapy in Patients With Resectable Rectal Cancer (KSCC1301).
Lead sponsor
Clinical Research Support Center Kyush
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2013
Completion date
August 31, 2020
Enrollment
110 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer